Announcements Trials
Browse Landscape

Phase

Phase 1 5

Status

Completed 161Recruiting 113Unknown 56Terminated 47Not yet recruiting 34Active not recruiting 15Withdrawn 5Enrolling by invitation 1

Sponsor Class

INDUSTRY 5OTHER 3

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Neoplasms 83Carcinoma, Non-Small-Cell Lung 79Breast Neoplasms 71Leukemia, Myeloid, Acute 39Colorectal Neoplasms 37Recurrence 36Prostatic Neoplasms 34Neoplasm Metastasis 30Multiple Myeloma 28Lymphoma 26Pancreatic Neoplasms 25Melanoma 25Lymphoma, Non-Hodgkin 24Lung Neoplasms 24Leukemia, Lymphocytic, Chronic, B-Cell 23Ovarian Neoplasms 22Lymphoma, Follicular 22Carcinoma, Hepatocellular 22Carcinoma, Renal Cell 21Stomach Neoplasms 19Squamous Cell Carcinoma of Head and Neck 19Lymphoma, Large B-Cell, Diffuse 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 18Leukemia 18Head and Neck Neoplasms 18Urinary Bladder Neoplasms 17Hematologic Neoplasms 14Carcinoma 13Uterine Cervical Neoplasms 12

Interventions

nirogacestat 1atezolizumab 1Topotecan 1Lapatinib 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × INDUSTRY × Advanced Solid Tumors × Clear all
NCT06235541 2025-07-17

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Genome & Company

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

NCT06719973 2025-06-17

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

EMD Serono

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

NCT02462707 2015-10-07

A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors

Pfizer

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

NCT00792558 2015-09-01

Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers

Bristol-Myers Squibb

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

NCT00682279 2015-04-17

A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors

GlaxoSmithKline

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡